de Groot IJM - Search Results

1

Decision-Making And Selection Bias in Four Observational Studies on Duchenne and Becker Muscular Dystrophy.

Naarding KJ, Doorenweerd N, Koeks Z, Hendriksen RGF, Chotkan KA, Krom YD, de Groot IJM, Straathof CS, Niks EH, Kan HE. Naarding KJ, et al. Among authors: de groot ijm. J Neuromuscul Dis. 2020;7(4):433-442. doi: 10.3233/JND-200541. J Neuromuscul Dis. 2020. PMID: 32925089 Free PMC article.

2

Prednisone 10 days on/10 days off in patients with Duchenne muscular dystrophy.

Straathof CS, Overweg-Plandsoen WC, van den Burg GJ, van der Kooi AJ, Verschuuren JJ, de Groot IJ. Straathof CS, et al. J Neurol. 2009 May;256(5):768-73. doi: 10.1007/s00415-009-5012-y. Epub 2009 Mar 22. J Neurol. 2009. PMID: 19306039 Free article.

3

Prevalence and psychosocial impact of lower urinary tract symptoms in patients with Duchenne muscular dystrophy.

van Wijk E, Messelink BJ, Heijnen L, de Groot IJ. van Wijk E, et al. Neuromuscul Disord. 2009 Nov;19(11):754-8. doi: 10.1016/j.nmd.2009.07.009. Neuromuscul Disord. 2009. PMID: 19853790

4

Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study.

Jansen M, de Groot IJ, van Alfen N, Geurts ACh. Jansen M, et al. BMC Pediatr. 2010 Aug 6;10:55. doi: 10.1186/1471-2431-10-55. BMC Pediatr. 2010. PMID: 20691042 Free PMC article. Clinical Trial.

5

Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial.

Buyse GM, Goemans N, van den Hauwe M, Thijs D, de Groot IJ, Schara U, Ceulemans B, Meier T, Mertens L. Buyse GM, et al. Neuromuscul Disord. 2011 Jun;21(6):396-405. doi: 10.1016/j.nmd.2011.02.016. Epub 2011 Mar 23. Neuromuscul Disord. 2011. PMID: 21435876 Clinical Trial.

6

Quantitative muscle ultrasound is a promising longitudinal follow-up tool in Duchenne muscular dystrophy.

Jansen M, van Alfen N, Nijhuis van der Sanden MW, van Dijk JP, Pillen S, de Groot IJ. Jansen M, et al. Neuromuscul Disord. 2012 Apr;22(4):306-17. doi: 10.1016/j.nmd.2011.10.020. Epub 2011 Nov 30. Neuromuscul Disord. 2012. PMID: 22133654

7

Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen.

ten Dam K, de Groot IJ, Noordam C, van Alfen N, Hendriks JC, Sie LT. ten Dam K, et al. Neuromuscul Disord. 2012 Jun;22(6):500-4. doi: 10.1016/j.nmd.2012.01.005. Epub 2012 Mar 4. Neuromuscul Disord. 2012. PMID: 22390890

8

Oral muscles are progressively affected in Duchenne muscular dystrophy: implications for dysphagia treatment.

van den Engel-Hoek L, Erasmus CE, Hendriks JC, Geurts AC, Klein WM, Pillen S, Sie LT, de Swart BJ, de Groot IJ. van den Engel-Hoek L, et al. J Neurol. 2013 May;260(5):1295-303. doi: 10.1007/s00415-012-6793-y. Epub 2012 Dec 23. J Neurol. 2013. PMID: 23263593

9

Assisted bicycle training delays functional deterioration in boys with Duchenne muscular dystrophy: the randomized controlled trial "no use is disuse".

Jansen M, van Alfen N, Geurts AC, de Groot IJ. Jansen M, et al. Neurorehabil Neural Repair. 2013 Nov-Dec;27(9):816-27. doi: 10.1177/1545968313496326. Epub 2013 Jul 24. Neurorehabil Neural Repair. 2013. PMID: 23884013 Clinical Trial.

10

Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy.

Mayhew AG, Cano SJ, Scott E, Eagle M, Bushby K, Manzur A, Muntoni F; North Star Clinical Network for Neuromuscular Disease. Mayhew AG, et al. Dev Med Child Neurol. 2013 Nov;55(11):1046-52. doi: 10.1111/dmcn.12220. Epub 2013 Aug 5. Dev Med Child Neurol. 2013. PMID: 23909763 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters